Cardiac disease in children with mild-to-moderate chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 17, Issue 3, 2008, Pages 292-297

  Schaefer, Franz ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Center for Pediatrics and Adolescent Medicine   (Germany)

Author keywords

Children; Chronic kidney disease; Left ventricular hypertrophy; Systolic function

Indexed keywords

ANEMIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILDHOOD MORTALITY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; GENDER; GEOMETRY; GLOMERULUS FILTRATION RATE; HEART AFTERLOAD; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART PRELOAD; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; OBESITY; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTOLIC DYSFUNCTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ECHOCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 42149166629     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282fb7bf2     Document Type: Review

References (58)

1. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15:1307-1315.
2. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489-495.
3. Chavers BM, Herzog CA. The spectrum of cardiovascular disease in children with predialysis chronic kidney disease. Adv Chronic Kidney Dis 2004; 11:319-327.
4. Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002; 62:648-653.
5. Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064-1075.
6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
7. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61:621-629.
8. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med 2004; 350:2654-2662.
9. Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 2002; 141:191-197.
10. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286-290.
11. Greaves SC, Gamble GD, Collins JF, et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24:768-776.
12. Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27:347-354.
13. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34:125-134.
14. Tucker B, Fabbian F, Giles M, et al. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure. Clin Nephrol 1999; 52:377-382.
15. Tucker B, Fabbian F, Giles M, et al. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 1997; 12:724-728.
16. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-192.
17. Paoletti E, Bellino D, Cassottana P, et al. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46:320-327.
18. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 2001; 16:318-323.
19. Ulinski T, Genty J, Viau C, et al. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 2006; 21:1171-1178.
20. Brunner FP, Fassbinder W, Broyer M, et al. Survival on renal replacement therapy: data from the EDTA Registry. Nephrol Dial Transplant 1988; 3:109-122.
21. Foley RN, Parfrey PS, Harnett JD, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5:2024-2031.
22. Daniels SR, Kimball TR, Morrison JA, et al. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 1995; 76:699-701.
23. Urbina EM, Gidding SS, Bao W, et al. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 1995; 91:2400-2406.
24. de Simone G, Kizer J, Chinali M, et al. Normalization for body size and population attributable risk of left ventricular hypertrophy: The Strong Heart Study. Am J Hypertens 2005; 18:191-196.
25. Matteucci MC, Wühl E, Picca S, et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006; 17:218-226.
26. de Simone G, Daniels SR, Kimball TR, et al. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic under-estimation. Hypertension 2005; 45:64-68.
27. Johnstone LM, Jones CL, Grigg LE, et al. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 1996; 50:998-1006.
28. Mitsnefes MM, Kimball TR, Witt SA, et al. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 2003; 107:864-868.
29. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10:1606-1615.
30. Mitsnefes MM, Kimball TR, Border WL, et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 2004; 65:1461-1466.
31. Mitsnefes MM, Kimball TR, Kartal J, et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006; 149:671-675.
32. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64.
33. Gruppen MP, Groothoff JW, Prins M, et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 2003; 63:1058-1065.
34. Gardner JD, Brower GL, Janicki JS. Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 2002; 8:101-107.
35. Weinberg EO, Mirotsou M, Gannon J, et al. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 2003; 12:113-127.
36. Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113:328-333.
37. Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 2004; 110:3488-3492.
38. Fox E, Taylor H, Andrew M, et al. Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study. Hypertension 2004; 44:55-60.
39. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 2000; 14:898-902.
40. Palcoux JB, Palcoux MC, Jouan JP, et al. Echocardiographic patterns in infants and children with chronic renal failure. Int J Pediatr Nephrol 1982; 3:311-314.
41. Foley RN, Parfrey PS, Morgan J, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58:1325-1335.
42. Levin A, Djurdjev O, Thompson C, et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 2005; 46:799-811.
43. McMahon LP, Roger SD, Levin A. Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol 2004; 15:1640-1647.
44. Roger SD, McMahon LP, Clarkson A, et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. J Am Soc Nephrol 2004; 15:148-156.
45. Schaefer F, Mehls O. Hypertension in chronic kidney disease. In: Portman RJ, Sorof JM, Ingelfinger JR, editors. Pediatric hypertension. Totowa, New Jersey: Humana Press; 2004. pp. 371-387.
46. London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 1997; 4:194-211.
47. Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol 2004; 56:279-288.
48. Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15:2186-2194.
49. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 17:229-232.
50. Olsen MH, Hjerkinn E, Wachtell K, et al. Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in longstanding hypertension? ICARUS: a LIFE substudy. J Hum Hypertens 2003; 17:305-311.
51. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38:938-942.
52. Litwin M, Wühl E, Jourdan C, et al. Abnormal morphology of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16:1494-1500.
53. de Simone G, Devereux RB, Celentano A, Roman MJ. Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hypertens 1999; 17:1001-1006.
54. de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
55. Chinali M, de Simone G, Matteucci MC, et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 2007; 18:593-598. In this study, midwall shortening is used for the first time to define left-ventricular systolic function in children with CKD. Systolic dysfunction was found in 48% of children with concentric left-ventricular hypertrophy.
56. de Simone G, Devereux RB, Koren MJ, et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93:259-265.
57. Mitsnefes MM, Kimball TR, Border WL, et al. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 2004; 43:721-726.
58. Weaver DJ Jr, Kimball TR, Knilans T, et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 2008 (epub ahead of print)